Portal hypertension is a key driver of life-threatening clinical complications such as bleeding from gastro-oesophageal varices, ascites and hepatic encephalopathy. It mostly develops in patients with advanced chronic liver disease (ACLD) but may also occur in vascular liver disease, most…
A dedicated clinical school on the use of concepts and skills of evidence-based care to solve controversial real-life problems in the management of cirrhosis. The course will focus on those areas of cirrhosis management where agreement is far from being…
The objective of the School is to foster the clinical formation of young hepatologists in the area of advanced liver disease, and in particular in the field of portal hypertension, where important advancements are in progress. The School is scheduled…
Liver cirrhosis is a major healthcare problem worldwide with a high mortality which is predominantly caused by complications of portal hypertension, e.g. variceal bleeding and ascites. Reduction of the portal pressure by implantation of a transjugular intrahepatic portosystemic shunt (TIPS) is the key in…
